
By Sharon Carothers, managing director at Sensis

By Claire Tomkins, CEO at Future Family

By Terry Weber, CEO at Biote

The research will compare the experiences of neurodivergent and neurotypical women at different stages of the menopausal transition

Israeli researchers tested the new drug and achieved a survival rate of 80 per cent

The submission is supported by data from more than 700 breast cancer patients across five clinical studies

By Leigh Coggiola-Belza, founder and CEO at Leaxy

Digestive disorders affect one in four Americans, with women accounting for nearly 60% of patients

97% of women felt they did not have all the information needed when first considering treatment

The company has partnered with the renowned American neuroscientist to help members better manage physiological stress